Discover 2,226 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Francisco offers opportunities for individuals interested in taking part in paid studies as healthy volunteers, as well as those looking for studies for a specific medical condition. The city has a strong emphasis on cutting-edge research for conditions such as HIV/AIDS, oncology, kidney disease, PCOS, and endometriosis, among others. By participating, you can gain access to the latest healthcare innovations and contribute to pioneering medical progress.
Filter
2
Filter results
Results: 2,226
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: San Francisco CA, Los Angeles CA, Duarte CA, Houston TX,
Sponsor: EvolveImmune United, Inc
Sex: All
Age: 18+
Code: NCT07217171
Phase1, Recruiting
Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation
for
Obstructive Sleep Apnea,
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 21+
Code: NCT07220525
Recruiting
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
for
Relapsed or Refractory Multiple Myeloma
Location: San Francisco CA, Milwaukee WI, Nashville TN,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 18+
Code: NCT07116616
Phase1, Phase2, Recruiting
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
for
Melanoma (Skin Cancer), Melanoma Stage IIIB-IV,
Location: San Francisco CA, Stanford CA, Newport Beach CA,
Sponsor: Linnaeus Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06624644
Phase2, Phase3, Recruiting
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
for
Relapsed AL Amyloidosis, Refractory AL Amyloidosis,
Location: San Francisco CA, Phoenix AZ, Calgary, Rochester MN,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07081646
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
Location: San Francisco CA, Palo Alto CA, Minneapolis MN,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06751043
Recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for
Cardiovascular Disease and Lipoprotein(a)
Location: San Francisco CA, Palo Alto CA, Stockton CA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07517263
Phase3, Recruiting
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: San Francisco CA, Los Angeles CA, Kansas City KS,
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Sex: All
Age: 18+
Code: NCT07223814
Phase3, Recruiting
Effect of Magnesium on Neuromonitoring
for
Spine, Pain, Spine Surgery, Spine Surgery With Neuromonitoring,
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT06975072
Recruiting
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
for
Primary Membranous Nephropathy
Location: San Francisco CA, Stanford CA, Fresno CA,
Sponsor: Biogen
Sex: All
Age: 18 - 70+
Code: NCT06962800
Phase3, Recruiting
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
for
Heart Diseases, Cardiovascular Disease
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT07087184
Recruiting
A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumors That Are MTAP Deficient
Location: San Francisco CA, Portland OR, Pittsburgh PA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06130553
Phase1, Phase2, Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
for
Delayed Graft Function, DGF, Kidney Transplant
Location: San Francisco CA, Stanford CA, Los Angeles CA,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06830798
Phase3, Recruiting
Primary Tumor Research and Outcomes Network
for
Spinal Column Tumor
Location: San Francisco CA, Vancouver, Rochester MN, Houston TX,
Sponsor: AO Innovation Translation Center
Sex: All
Age: 0+
Code: NCT02790983
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for
Obstructive Hypertrophic Cardiomyopathy
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05489705
Recruiting
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
for
Spinal Injuries, Spinal Deformity
Location: San Francisco CA, Louisville KY, Durham NC, New York NY
Sponsor: Columbia University
Sex: All
Age: 18 - 70+
Code: NCT02314988
Phase2, Phase3, Recruiting
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
for
Rheumatic Joint Disease
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,